APCER PHARMA to Demonstrate Cost-Effective Drug Safety, Regulatory Services and Risk Management Solutions for Generic Pharmaceutical Companies at the GPhA Annual Meeting

PRINCETON, NJ – February 16, 2010 – APCER PHARMA (“APCER”) executives will discuss and demonstrate their expertise in providing generic drug manufacturers with the best in class pharmacovigilance/drug safety, regulatory and risk management services at the GPhA Annual Meeting, February 16-18, at the Ritz-Carlton in Naples, Florida. APCER will be in Booth #27.

APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

APCER President and CEO Suneet Walia explained, “APCER is repeatedly chosen as the safety and regulatory services provider by pharmaceutical companies because our team knows what it takes to provide a compliant, best in class solution, at a very effective price.”

APCER uses leading systems on a secure, hosted platform to handle customers’ requirements at virtually a fraction of the cost of what it would normally cost a company to implement their own system. The team at APCER is experienced and the operations truly global. APCER currently does case reporting on behalf of its clients in 68 countries and has a team on the ground in North America, Europe and Asia that works closely with its customers to provide round the clock service.

To arrange a personal meeting with APCER executives please contact Ronald Lillie at This e-mail address is being protected from spambots. You need JavaScript enabled to view it , or call 609-455-1600.

About APCER PHARMA

APCER PHARMA provides comprehensive drug safety, regulatory services and risk management programs to pharmaceutical, biotechnology, medical device, and consumer products companies. APCER provides customers with hosted safety data systems; service to receive, process, code and report (including electronic reporting) Adverse and Serious Adverse Events on behalf of its clients; and, other strategic Risk Management and Regulatory services. APCER’s scalable, rapid deployment processes ensure compliance, comprehensive understanding of a customer’s requirements and implementation of solutions that address current and future needs. For more information, visit www.apcerpharma.com or call 1-877-APCER-NA.

Media contact: Brenda Nashawaty, This e-mail address is being protected from spambots. You need JavaScript enabled to view it , 617-688-3253